ABSTRACT PURPOSE: To evaluate the 1-year results of corneal collagen cross-linking (CXL) in eyes with postoperative excimer laser refractive surgery corneal ectasia.
RESULTS:
Best spectacle-corrected visual acuity (BSCVA) improvement was statistically signifi cant (PϽ.05) beyond 6 months after surgery (improvement of 0.1 logMAR at 1 year). Mean spherical equivalent refraction and mean refractive sphere reduction (improvement of 1.40 and 1.44 diopters [D] , respectively) were statistically signifi cant (PϽ.05) at 6 months postoperatively. At 1 year after CXL, mean endothelial cell count and keratometry (average SimK decrease of 2.02 D) as well as Klyce and Ambrósio indices did not deteriorate. Coma and spherical aberration did not change signifi cantly. Mean pupil center pachymetry and corneal thickness at 0 and 2 mm from the thinnest corneal point decreased signifi cantly. I dentifi cation of eyes at risk for ectasia after excimer laser refractive surgery remains diffi cult and controversial, and ectasia after excimer laser corneal refractive surgery involves more often postoperative LASIK eyes, but it may also occur after photorefractive keratectomy (PRK). [1] [2] [3] The occurrence of ectasia is dramatic for both the patient and the physician, and eventually penetrating keratoplasty may be required. 1 The successful introduction of corneal collagen cross-linking (CXL) in the armamentarium for the treatment of keratoconus-related ectasia provided a new tool for the management of ectasia consequent to excimer laser refractive surgery. The limited invasiveness as well as the potential for repeatability of CXL make it an ideal treatment for these refractive surgery patients who, after looking for a solution to an unpleasant situation such as a signifi cant myopic refractive defect, fi nd themselves in an optically worse situation, with apparently endless instability and progression.
We present our experience with CXL in the treatment of postoperative excimer laser refractive surgery corneal ectasia.
PATIENTS AND METHODS

STUDY POPULATION
Thirteen eyes of nine consecutive patients (six women, three men) in whom postoperative excimer laser refractive surgery ectasia progression was detected in the preceding 6 months were enrolled at the Cornea Service of the Ophthalmology Department of Istituto Clinico Humanitas (Rozzano, Milan, Italy) from September 2007 to September 2008 in this prospective, nonrandomized, single-center study, representing an interim analysis of a subpopulation.
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Mean patient age was 42 years (range: 30 to 59 years). Of the treated eyes, six were right eyes and seven were left eyes.
Inclusion criteria were previous excimer laser refractive surgery, a documented ectasia progression in the previous 6 months, corneal thickness of at least 350 µm at the thinnest point, and age (as specifi ed by our institution's ethical committee) 18 to 60 years.
Preoperative ectasia progression was confi rmed by serial differential corneal topography and by differential optical pachymetry analysis in all eyes included in the study. 4 Ectasia progression was defi ned as a change in either myopia and/or astigmatism of at least 3.00 diopters (D) total over the previous 6 months, or a mean change in central and/or pupillary keratometry (K) reading of a total of at least 1.50 D observed in three consecutive topographies over the preceding 6 months, or a total mean central corneal thickness decrease of at least 5% in three consecutive tomographies performed over the previous 6 months.
Exclusion criteria were corneal thickness Ͻ350 µm at the thinnest point, a history of herpetic keratitis, severe dry eye, concurrent corneal infections, corneal opacities, concomitant autoimmune diseases, and any previous non-excimer laser refractive ocular surgery. [5] [6] [7] [8] [9] Pregnant or nursing women, patients with poor compliance, and patients wearing rigid gas permeable lenses for at least 4 weeks before baseline examination were also excluded.
Criteria for aborting the study itself included a reduction in endothelial cell density of more than 50% in Ͼ2 eyes, the development of corneal haze grade 3-4 (Hanna scale) in Ͼ5% of eyes, a loss of Ͼ2 lines of best spectacle-corrected visual acuity (BSCVA) in Ͼ5% of eyes, and the detection of lens opacities in Ͼ1% of treated eyes when compared to untreated eyes (LOCS II classifi cation).
The study received institutional review board approval by the ethical committee of Istituto Clinico Humanitas and was conducted according to the ethical standards set in the 1964 Declaration of Helsinki, as revised in 2000. All patients signed a specifi c informed consent form.
At baseline and at each postoperative follow-up examination (3, 6 , and 12 months), all patients underwent uncorrected visual acuity (UCVA) and BSCVA assessment, slit-lamp microscopy, basal Schirmer test, Goldmann tonometry, dilated fundus examination, endothelial biomicroscopy (Konan Specular Microscope; Konan Medical Inc, Hyogo, Japan), and corneal topography as well as corneal, internal, and total aberrometry with the Optical Path Difference Scan platform (OPD-Scan; NIDEK, Gamagori, Japan) and Pentacam optical pachymetry and Scheimpfl ug-based topo/ tomography (Oculus Inc, Lynnwood, Washington).
All patients previously had excimer laser refractive surgery, either PRK (n=3 eyes) or LASIK (n=10 eyes), and were referred from other centers. The reasons for biomechanical instability after excimer laser refractive surgery was due to formerly undiagnosed forme fruste keratoconus in 5 eyes and high correction with reduced residual corneal thickness in 3 eyes. The cause could not be identifi ed in the remaining 4 eyes.
VISUAL ACUITY ASSESSMENT
Visual acuity was assessed with the Early Treatment Diabetic Retinopathy Study (ETDRS) logMAR charts (Lighthouse International, New York, New York) based on the design suggested by Bailey and Lovie 10 and incorporating the recommendations of the US National Academy of Sciences-National Research Council. 11 The chart has been described in detail by Ferris et al. 12 Measurements were made with best correction after a non-cycloplegic refraction at 4 m.
CORNEAL TOPOGRAPHY
Corneal topography was performed with the topographer feature of the OPD-Scan, analyzed with a Placido disk 6480 points over an 11-mm diameter, a 94.98 mm 2 corneal surface area. The examination was performed in photopic conditions. The OPD-Scan was also used to study the 21 Klyce indices provided by the Corneal Navigator Topo-Classifi er Map. [13] [14] [15] [16] Oculus Pentacam HR (Oculus Optikgeräte, Wetzlar, Germany) provided analysis of the seven Ambrósio keratoconus indices. 17 
WAVEFRONT ANALYSIS
Corneal wavefront analysis was performed with the OPD-Scan. The device was also used to objectively analyze mean refraction. The OPD-Scan further provides an aberrometric analysis of the eye, decomposing whole eye (total) aberrations into corneal aberrations and internal aberrations. For the purpose of this study, only corneal aberrations for a 6-mm pupil were considered.
CORNEAL AND ANTERIOR CHAMBER ANALYSIS
Anterior chamber analysis was performed with the Pentacam HR. [18] [19] [20] [21] [22] The analyses performed with the Pentacam included pupil center pachymetry and the pachymetry of the thinnest point of the cornea. The distance of these two points from the corneal apex is shown by x and y coordinates.
Total and partial corneal volume is calculated in a ring around the apex, using diameters of 3, 5, 7, and 10 mm. Anterior chamber volume is calculated by measuring the distances between the back surface of the cornea and the iris-lens plane over a 12-mm diameter. Anterior chamber depth is measured from the endothelium of the corneal apex to the iris-lens plane. Anterior and posterior elevation maps use a toric reference body, with calculations based on the central radii and the eccentricity of the keratometry measurements.
ENDOTHELIAL CELL COUNT
Endothelial biomicroscopy was performed manually according to the method described by Prinz et al. 23 Cell centers of at least 50 contiguous cells were identifi ed by aligning a cursor on the cell apices and endothelial cell density was recorded. The Konan Noncon Robo (Konan Medical Inc, Nishinomiya, Hyogo, Japan) device was used.
CROSS-LINKING PROCEDURE
The surgical technique has been described elsewhere. 24 All patients underwent CXL on a day-surgery basis. Thirty minutes before the procedure pain medication was administered and 2% pilocarpine drops were instilled in the eye to be treated. Pupil diameter reduction was planned to protect the retina from ultraviolet A (UVA) radiation (amount of radiation is proportional to the square value of pupil diameter).
The procedure was conducted under sterile conditions in the operating suite. After topical anesthesia with two applications of 4% lidocaine drops and oxybuprocaine hydrochloride 0.2%, the patient was draped, the ocular surface was rinsed with sterile physiological balanced salt solution, and a lid speculum was applied. The corneal epithelium was manually abraded cautiously in a central 9-mm diameter area. No lifting of the fl ap margin was observed.
Before beginning UVA irradiation, photosensitizing ribofl avin 0.1% solution (10 mg ribofl avin-5-phosphate in 20% dextran-T-500 10 mL solution) (Ricrolin; SOOFT italia S.p.A., Montegiorgio [AP], Italy) was applied to the cornea every minute for 30 minutes to achieve adequate penetration of the solution. This treatment was performed only when corneal thickness, including the epithelium, was у400 µm.
In three eyes, corneal thickness ranged between the minimum usually accepted for CXL, 350 to 450 µm, thus before irradiation, corneal thickness expansion by swelling was performed as follows. Photosensitizing ribofl avin 0.1% solution was applied to the cornea every minute for 20 minutes as described above. Then, hypotonic ribofl avin-5-phosphate solution without dextran-T-500 (Vitamin B2 Streuli; Streuli Pharma AG, Uznach, Switzerland) was applied on the corneal surface for 5 minutes, and intraoperative pachymetry was performed. If corneal thickness was Ͻ400 µm, this procedure was repeated. Usually, 15 minutes of ribofl avin-5-phosphate solution application was necessary to properly expand corneal thickness. Once 400 µm was reached, the procedure went on to the following step.
Using a slit lamp with the blue fi lter, the surgeon confi rmed the presence of ribofl avin in the anterior chamber before UVA irradiation was started. The cornea was exposed to a UVA source emanating from a solid-state device (UV-X System; Peschke Meditrade GmbH, Huenenberg, Switzerland), which emits light at a wavelength of 370Ϯ5 nm and an irradiance of 3 mW/cm 2 or 5.4 J/cm 2 . Exposure lasted for 30 minutes, during which time the 0.1% ribofl avin solution was again applied, this time once every 5 minutes. The cropped light beam has a 7.5-mm diameter. A calibrated UVA meter (LaserMate-Q; Laser 2000, Wessling, Germany) was used before treatment to check the irradiance at a 1.0-cm distance. The Peschke laser emission probe has one central and six peripheral light emitting diodes (LED). Fixation during irradiation was achieved by instructing the patient to focus on the central LED of the probe. During the procedure, the surgeon also checked for centration of treatment. Both topical anesthetics were added as needed during irradiation.
Postoperatively, patients received cyclopentolate (Ciclolux; Allergan, Rome, Italy) and levofl oxacin 0.5% drops (Oftaquix; Tubilux Pharma, Pomezia, Rome, Italy). A soft bandage contact lens was applied until reepithelialization was complete. Topical levofl oxacin was given four times daily for 7 days, dexamethasone 21-phosphate 0.15% drops (Etacortilen; Sifi , Lavinaio [CT] Italy) three times daily for 20 days, and 0.15% sodium hyaluronate drops (BluYal; SOOFT italia S.p.A.) six times daily for 45 days. In addition, all patients received oral amino acid supplements (Aminoftal, SOOFT italia S.p.A.) for 7 days. 25 Patients were examined every day until re-epithelialization was complete and then at 1, 3, 6, and 12 months.
DATA ANALYSIS
Statistical analyses were performed with the Statistica (StatSoft Inc, Tulsa, Oklahoma) computer package. All data are reported as meanϮstandard deviation. Normality of the data was tested using the Kolmogorov-Smirnov test and the normal probability plot. The level of statistical signifi cance was set at PϽ.05.
RESULTS
Mean re-epithelialization time was 48Ϯ15 hours (range: 21 to 75 hours). All eyes attained at least CXL for Ectasia After Excimer Laser Surgery/Vinciguerra et al 3-month follow-up; maximum follow-up was 12 months for 7 eyes (mean: 11 months, range: 3 to 17 months).
VISUAL ACUITY AND REFRACTIVE RESULTS
Uncorrected visual acuity and BSCVA data, expressed in logMAR, throughout the entire follow-up period are summarized in Table 1 .
Uncorrected visual acuity did not change significantly during follow-up. Best spectacle-corrected visual acuity improvement was statistically signifi cant beyond 6 months postoperatively (20/25) when compared to preoperative levels (20/35) .
Refractive results are also presented in Table 1 . The reductions in spherical equivalent refraction and mean sphere value were statistically signifi cant at 6 months, but not at 12 months.
TOPOGRAPHIC RESULTS
Topographic astigmatism measured with the OPDScan during follow-up is shown in Table 2 . Mean baseline fl attest meridian keratometry, steepest meridian keratometry, and mean keratometry change over 12 months was not statistically signifi cant.
The Klyce indices 16 obtained with the Nidek OPDScan were analyzed in treated and untreated eyes at baseline and at 3, 6, and 12 months (Table 3) . At 3 months postoperative, the Klyce indices coeffi cient of variation of corneal power, logMAR, and area compensated surface regularity index had signifi cantly increased, whereas the index standard deviation of corneal power had signifi cantly decreased. asymmetry had signifi cantly increased and the keratoconus center index had signifi cantly decreased. 17 
ABERROMETRIC RESULTS
Aberrometric results are shown in Table 5 . Mean corneal coma, spherical aberration, and high order astigmatism had decreased by 1-year follow-up, but the difference was not statistically signifi cant when compared with preoperative data. Table 6 presents changes in corneal and anterior 
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chamber morphological values measured by means of Pentacam optical pachymetry. Pupil center pachymetry and corneal pachymetry at the thinnest point total corneal showed a statistically signifi cant decrease over the entire follow-up period.
Anterior chamber volume did not change significantly, anterior chamber depth showed a statistically signifi cant increase at 3 months, and anterior and posterior elevation values did not show a signifi cant change. Total corneal volume showed signifi cant decrease at 3 months. Mean baseline, 3-, 6-, and 12-month corneal thickness values at 0, 2, 4, 6, and 8 mm from the thinnest corneal point are presented in Table 6 . A limited (Ϫ9.0%) but statistically signifi cant decrease in corneal thickness was found at 0 mm and 2 mm after 3-month follow-up. This decrease remained stable over the entire follow-up period. A similar significant decrease at 4 mm was observed only at 12-month follow-up.
ENDOTHELIAL RESULTS
Mean baseline endothelial cell count was 2555Ϯ470 cells/mm 2 ). The difference between baseline and 12 months was not statistically signifi cant, indicating that CXL did not induce endothelial damage in the 1-year follow-up period.
No ocular or systemic adverse events were observed, as well as no epithelial ingrowth or diffuse lamellar keratitis, and no signifi cant intraocular pressure changes were noted. Subjectively, patients perceived improvement of UCVA during the fi rst 6 postoperative months. Between 6 and 12 months, they reported a continuing increase in BSCVA.
DISCUSSION
Ectasia after LASIK and, generally, excimer laser refractive surgery, is receiving increasing interest due to its dramatic negative effect on visual quality and potential for litigation. 2, 26, 27 Traditional treatment for ectasia after excimer laser refractive surgery follows the keratoconus scheme, including rigid gas permeable contact lenses and intracorneal ring segments, but the most frequent choice remains corneal transplantation. 3, 28 Recently, after the success observed with keratoconus, several studies reported CXL treatment for postoperative LASIK ectasia.
The fi rst case report of CXL in postoperative LASIK keratectasia was published in 2005 by Kohlhaas et al. 29 A similar case report by Kanellopoulos 30 was published in 2007, with PRK applied after CXL. In the same year, Hafezi et al 31 reported 10 contact lens-intolerant eyes, with 1-year follow-up, observing stabilization in 5 eyes 
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The implantation of Intacs SK (Addition Technology Inc, Des Plaines, Illinois) has also been considered an adjunct to CXL. 34 Regarding the success of CXL in the treatment of postoperative LASIK ectasia, Hafezi and Iseli 35 reported a case of bilateral iatrogenic keratectasia that occurred during a patient's fi rst pregnancy 26 months after LASIK. Cross-linking was performed in both eyes, leading to stabilization and even to improvement in keratometric steepness over 22 months. However, during a second pregnancy, exacerbation of postoperative LASIK keratectasia occurred, despite previous CXL.
For this reason, pregnant women were not included in the present study.
From a psychological point of view, refractive surgery patients with corneal ectasia may be profoundly different from keratoconus patients, in that they are used to having complete refractive correction with good visual acuity and thus may complain immediately when visual disturbances occur due to early ectatic changes. Moreover, when postoperative LASIK eyes-the most frequent victims of iatrogenic ectasia-are considered, the amount of residual corneal thickness may be limited. After a 140-µm fl ap and 130-µm ablation, a normal CXL for Ectasia After Excimer Laser Surgery/Vinciguerra et al 530-µm cornea has limited residual central thickness, and an ectatic one may have even less. Thus, we considered the selection criteria for CXL adopted for keratoconic eyes only partially valid for eyes with ectasia consequent to excimer laser refractive surgery. A proven corneal curvature instability as well as no endothelial cell reduction were mandatory, but we did not accept minimal corneal thickness of 400 µm as an absolute limit. Because progressing ectasia may lead to penetrating keratoplasty, we chose to apply a corneal expansion procedure with ribofl avin-5-phosphate solution application in corneas thinner than 400 µm. 36 To date, the three eyes treated in this way have not shown any complications and behaved similarly to the other eyes with thicker corneas.
We followed the inclusion criteria specifi ed by the ethical committee of our institution for non-pediatric CXL, and this included an age limitation (18 to 60 years). However, no patient with ectasia after excimer laser refractive surgery outside this age range was encountered.
In this study, we observed corneal changes similar but less marked than those observed after CXL in keratoconic eyes. 24, 37 As in keratoconus, the situation remained stable up to 6 months. At the 6-month interval, we noticed improvement in refraction and BSCVA. Traditional topographic indices indicate that corneal curvature remained stable at the 1-year interval. Because simulated keratometry values do not consider the entire corneal surface, we analyzed the Klyce and Ambrósio indices for keratoconus. Four Klyce indices showed signifi cant variation at 3 months, but were stable with respect to preoperative values after 6 months. One Ambrósio index, index of vertical asymmetry, increased at 6 months, whereas another, center keratoconus index, decreased at 6 months. The index of vertical asymmetry is an index that is elevated in cases of oblique astigmatism, in keratoconus, or in ectasia. The center keratoconus index decreases with decreasing severity of central keratoconus. This improvement may be consistent with the fact that an ectatic cornea following excimer laser refractive surgery may show the most prominent curvature variation almost centrally and CXL may lead to improvement in this central corneal portion. Thus, there was apparent corneal curvature stabilization and also a tendency towards central fl attening, with improvement of the refractive situation. This is in accordance with the study by Hafezi and Iseli. 35 In summary, the Klyce and Ambrósio indices did not deteriorate at 1 year.
The following concept is important for understanding visual improvement in these patients. After myopic refractive ablation, the postoperative LASIK cornea is an oblate surface, with a centrally fl attened optical zone. In its initial phases, ectasia consequent to excimer laser refractive surgery appears topographically as a steepened, hypercurved area inside this fl attened optical zone. It is our impression that this steepened area reduces the extension of the fl attened optical zone, inducing a topographic pattern that resembles optical zone decentration. If treatment with CXL reduces the curvature of this area, the optical zone should partially regain its initial aspect. The aberrometric result of ectasia induced by excimer laser refractive surgery is the induction of coma, and the CXL-induced reduction of ectasia should lead to coma reduction.
Corneal CXL appeared to stabilize these iatrogenically ectatic eyes. Reduction in sphere, increase in BSCVA, apparent central corneal fl attening, and tendency to decrease coma at the 6-month interval may indicate a tendency towards improvement of the ectatic situation, with possible partial recentration of the optical zone.
The decrease in corneal thickness, on the other side, is consistent with what is observed in eyes with keratoconus, where linkage and stiffening of corneal stromal fi bers lead to corneal volume reduction. 24, 37 Effective duration of CXL effect remains to be ascertained. In our long-term keratoconus cohort, we did not have to retreat any eye. 37 Confocal microscopy studies document recolonization of anterior and intermediate stroma as well as no endothelial damage, thus suggesting that CXL treatment may be safely repeated in time.
Among complications of CXL in postoperative LASIK corneal ectasia, diffuse lamellar keratitis has been reported. 38 We did not observe any complications, such as epithelial ingrowth, diffuse lamellar keratitis (sands of the Sahara), or elevations of the fl ap margin.
Finally, the psychological effect of corneal CXL in postoperative LASIK eyes must be considered. A patient who underwent refractive surgery to reduce the daily burden of a refractive defect, and, after a few years, experiences highly ectasia-related unstable refraction, as well as a new and more dramatic ocular surgery such as penetrating keratoplasty, ends up again with a marked, lifestyle-limiting refractive defect. In our experience, patients with ectatic corneas after LASIK who had to undergo penetrating keratoplasty often developed resentment towards their surgeon, leading to medical malpractice cases.
Corneal collagen CXL intervenes in this process as a surgical procedure of limited invasiveness. Patients in this cohort perceived this treatment as an important and positive evolution in their situation, after a period of progressive worsening.
Limitations of this study are the interim analysis of a subpopulation, the number of eyes considered, and the incomplete follow-up for some patients. A larger group with longer follow-up will produce more enlightening information on the long-term behavior of eyes with corneal ectasia consequent to excimer laser refractive surgery after treatment with CXL.
Corneal collagen CXL appears to improve BSCVA in eyes with ectasia after excimer laser refractive surgery. No deterioration of the Klyce and Ambrósio indices or permanent side effects were observed. 
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